November 16, 2016
A Delaware federal judge found Merck Sharp & Dohme Corp.'s asserted claims on its Nasonex patent valid on Wednesday, though she cleared Teva Pharmaceuticals of infringement allegations triggered by an abbreviated new drug application for a generic version of the popular nasal spray.
July 22, 2015
A Delaware federal judge on Wednesday dismissed Merck Sharp & Dohme Corp.'s suit claiming Teva Pharmaceuticals USA Inc. is infringing its patent by intending to produce and sell a generic version of the popular nasal spray Nasonex, adopting a magistrate judge's advice to toss the case.
July 01, 2015
A Delaware magistrate judge on Wednesday recommended the court dismiss Merck Sharp & Dohme Corp.'s suit claiming Teva Pharmaceuticals USA Inc. is infringing its patent by intending to produce and sell a generic version of the popular nasal spray Nasonex.
July 03, 2014
Merck Sharp & Dohme Corp. sued Teva Pharmaceuticals USA in Delaware federal court on Thursday, alleging Teva's plans to manufacture a generic version of the popular nasal spray Nasonex infringe on Merck's patent on the drug.